

NCT02831166 comparison:

Summary:
CHIA has 16 criteria while your personal folder has 16 criteria
Total found criteria: 16/16
Total not Found: 0/16
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ ST-segment elevation acute myocardial infarction   │ ST-segment elevation acute myocardial infarction   │
│ patients during the first 12 hours of sympton      │ patients during the first 12 hours of sympton      │
│ onset                                              │ onset                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Intention to perform primary percutaneous coronary │ Intention to perform primary percutaneous coronary │
│ intervention                                       │ intervention                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Signed informed consent                            │ Signed informed consent                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient eligible for transradial and transfemoral  │ Patient eligible for transradial and transfemoral  │
│ primary percutaneous coronary intervention, being  │ primary percutaneous coronary intervention, being  │
│ pre-requisites: (a) familiarity of the operator    │ pre-requisites: (a) familiarity of the operator    │
│ with the radial and femoral techniques using       │ with the radial and femoral techniques using       │
│ vascular closure devices, (b) agreement of the     │ vascular closure devices, (b) agreement of the     │
│ operator to use the access route determined by the │ operator to use the access route determined by the │
│ randomization process                              │ randomization process                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Less than 18 years of age                          │ Less than 18 years of age                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnancy                                          │ Pregnancy                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Chronic use of vitamin K antagonists or direct     │ Chronic use of vitamin K antagonists or direct     │
│ thrombin inhibitors, or oral Xa-factor antagonists │ thrombin inhibitors, or oral Xa-factor antagonists │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hypersensitivity to antiplatelet and/or            │ Hypersensitivity to antiplatelet and/or            │
│ anticoagulant drugs                                │ anticoagulant drugs                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Active bleeding or high bleeding risk (severe      │ Active bleeding or high bleeding risk (severe      │
│ liver failure, active peptic ulcer, creatinine     │ liver failure, active peptic ulcer, creatinine     │
│ clearance < 30 mL/min, platelets count < 100.000   │ clearance \< 30 mL/min, platelets count \< 100.000 │
│ mm3)                                               │ mm3)                                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Uncontrolled systemic hypertension                 │ Uncontrolled systemic hypertension                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Cardiogenic shock                                  │ Cardiogenic shock                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous myocardial revascularization surgery with │ Previous myocardial revascularization surgery with │
│ = 1 internal mammary or radial artery graft        │ ≥ 1 internal mammary or radial artery graft        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Documented chronic peripheral arterial disease     │ Documented chronic peripheral arterial disease     │
│ preventing the use of the femoral technique        │ preventing the use of the femoral technique        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe concomitant disease with life expectancy    │ Severe concomitant disease with life expectancy    │
│ below 12 months                                    │ below 12 months                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Participation in drug or devices investigative     │ Participation in drug or devices investigative     │
│ clinical trials in the last 30 days                │ clinical trials in the last 30 days                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Medical, geographic or social conditions impairing │ Medical, geographic or social conditions impairing │
│ the participation in the study or inability to     │ the participation in the study or inability to     │
│ understand and sign the informed consent term      │ understand and sign the informed consent term      │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛